These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2482963)

  • 1. Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo.
    Aimone LD; Yaksh TL
    Peptides; 1989; 10(6):1127-31. PubMed ID: 2482963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro.
    Ray NJ; Jones AJ; Keen P
    Br J Pharmacol; 1991 Apr; 102(4):797-800. PubMed ID: 1713104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices.
    Ueda M; Sugimoto K; Oyama T; Kuraishi Y; Satoh M
    Neuropharmacology; 1995 Mar; 34(3):303-8. PubMed ID: 7630485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
    Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
    Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal capsaicin treatment abolishes the modulations by opioids of substance P release from rat spinal cord slices.
    Pohl M; Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F
    Neurosci Lett; 1989 Jan; 96(1):102-7. PubMed ID: 2467229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord.
    Mauborgne A; Lutz O; Legrand JC; Hamon M; Cesselin F
    J Neurochem; 1987 Feb; 48(2):529-37. PubMed ID: 2432185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord.
    Collin E; Mauborgne A; Bourgoin S; Mantelet S; Ferhat L; Hamon M; Cesselin F
    Neuroscience; 1992 Nov; 51(2):347-55. PubMed ID: 1281527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material.
    Benoliel JJ; Collin E; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
    Brain Res; 1994 Aug; 653(1-2):81-91. PubMed ID: 7982079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at delta opioid receptors.
    Collin E; Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F
    Neuropeptides; 1994 Jul; 27(1):75-83. PubMed ID: 7969822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release.
    Kondo I; Marvizon JC; Song B; Salgado F; Codeluppi S; Hua XY; Yaksh TL
    J Neurosci; 2005 Apr; 25(14):3651-60. PubMed ID: 15814796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta- and kappa-opioid agonists inhibit plasma extravasation induced by bradykinin in the knee joint of the rat.
    Green PG; Levine JD
    Neuroscience; 1992 Jul; 49(1):129-33. PubMed ID: 1328929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.
    Chang HM; Berde CB; Holz GG; Steward GF; Kream RM
    Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release.
    Collin E; Bourgoin S; Ferhat L; Hamon M; Cesselin F
    Neurosci Lett; 1992 Jan; 134(2):238-42. PubMed ID: 1317026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
    Suarez-Roca H; Maixner W
    J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation.
    Benoliel JJ; Bourgoin S; Mauborgne A; Legrand JC; Hamon M; Cesselin F
    Neurosci Lett; 1991 Apr; 124(2):204-7. PubMed ID: 1648690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices.
    Heijna MH; Padt M; Hogenboom F; Schoffelmeer AN; Mulder AH
    Neuroendocrinology; 1991 Aug; 54(2):118-26. PubMed ID: 1662785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
    Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P release from knee joint afferent terminals: modulation by opioids.
    Yaksh TL
    Brain Res; 1988 Aug; 458(2):319-24. PubMed ID: 2463049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.